Product Images Norethindrone And Ethinyl Estradiol And Ferrous Fumarate

This is a medication label for T ‘ROLUSP tablets which contain Narethindrone and Ethiyl Estradiol. The tablets are chewable and should be stored at a temperature of 25°C71°F or 15°C to 30°C (59°F to 86F). It also contains Ferrgus Fumarate tablets and mentions storage conditions for those tablets as well. The label appears to belong to a product manufactured in India by Naari Pte Ltd.*

This text provides information on various studies conducted to determine the risk of breast cancer associated with the use of combined oral contraceptives. The studies include NICHD Women's Contraceptive Study from 2002, French E3N cohort Study from 2005, Shanghai Women's Health Study from 2009, The Nurses' Health Study II from 2010, Oxford Family Planning Association Study from 2013, and Danish Sex Hormone Register Study from 2017. The text also includes effect estimates (OR/RR) for each study.*

The text is a chart that presents different methods of birth control and their effectiveness in preventing pregnancies. It lists various options like pregnancy projections, intrauterine devices, sterilization, birth control pills, patches, condoms, diaphragms, spermicides, withdrawal, and abstinence. The chart indicates that using different birth control methods can lead to fewer pregnancies per 100 women, while not using birth control can result in more pregnancies.*

This text seems to be a label with information about medication. The medication seems to be a combination of Norethindrone and Ethyl Estradiol in the form of chewable tablets that are stored at a temperature of 25°C. There is also a reference to Ferrous Fumarate tablets with storage information and mention of USP control. The label is manufactured by a company called Naari PTE Ltd. and made in India.*